A carregar...

Synthesis and In Vitro and In Vivo Evaluation of [(3)H]LRRK2-IN-1 as a Novel Radioligand for LRRK2

PURPOSE: LRRK2 (leucine-rich repeat kinase 2) has recently been proven to be a promising drug target for Parkinson’s disease (PD) due to an apparent enhanced activity caused by mutations associated with familial PD. To date, there have been no reports in which a LRRK2 inhibitor has been radiolabeled...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Imaging Biol
Main Authors: Malik, Noeen, Gifford, Andrew N, Sandell, Johan, Tuchman, Daniel, Ding, Yu-Shin
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5597475/
https://ncbi.nlm.nih.gov/pubmed/28289968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11307-017-1070-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!